SEC 13F Intelligence

Managers / Q3 2019 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$198M
Q3 2019
Positions
45
Filings on Record
30
2019–present window
Filed
Nov 12, 2019
original filing

Summary

Sivik Global Healthcare LLC reported $198M in U.S.-listed holdings across 45 positions for Q3 2019.

Its largest position, BSX, represents 4.1% of the portfolio.

Compared with Q2 2019, the fund opened 3 new positions and exited 19.

Portfolio Metrics

Turnover
+11.8%
vs prior filed quarter
Top-10 Concentration
+35.5%
share of reported value
Largest Position
+4.1%
Boston Scientific Corp Com Stk
New / Exited
3 / 19
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 89.4%ADR: 8.1%Other: 2.5%
  • Common Stock · 89.4% · $177M
  • ADR · 8.1% · $16M
  • Other · 2.5% · $5M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ALCALCON INCNEW+100.0K100.0K+$6M$6M
ZTSZOETIS INCNEW+30.0K30.0K+$4M$4M
CICIGNA CORPORATION COM STKNEW+20.0K20.0K+$3M$3M
GRFSGRIFOLS S A ADRADDED+195.0K295.0K+$4M$6M
PUT SPY 07/19/19 295 STANDARD & POORS DEPOSITORYSOLD OUT−5.5K0−$161M$0
PFEPFIZER INCSOLD OUT−150.0K0−$6M$0
MOHMOLINA HEALTHCARE INC COM STKSOLD OUT−40.0K0−$6M$0
ELANELANCO ANIMAL HEALTH INCSOLD OUT−150.0K0−$5M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

45 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1BSXBOSTON SCIENTIFIC CORP COM STKhistory →Cash Securities4.11%$8M200.0K
2UHSUNIVERSAL HEALTH SERVICES INC CL Bhistory →Cash Securities3.75%$7M50.0K
3HUMHUMANA INC COM STKhistory →Cash Securities3.74%$7M29.0K
4HCAHCA HEALTHCARE INChistory →Cash Securities3.65%$7M60.0K
5MRKMERCK & COhistory →Cash Securities3.61%$7M85.0K
6VRTXVERTEX PHARMACEUTICALS INC COM STKhistory →Cash Securities3.42%$7M40.0K
7ABTABBOTT LABORATORIEShistory →Cash Securities3.38%$7M80.0K
8BAXBAXTER INTL INC COM STKhistory →Cash Securities3.31%$7M75.0K
9DHRDANAHER CORP COM STKhistory →Cash Securities3.28%$6M45.0K
10SNYSANOFI ADRhistory →Cash Securities3.27%$6M140.0K
11LLYELI LILLY & COhistory →Cash Securities3.10%$6M55.0K
12BIOBIO-RAD LABORATORIES INC CL A COM STKhistory →Cash Securities3.02%$6M18.0K
13GRFSGRIFOLS S A ADRhistory →Cash Securities2.98%$6M295.0K
14ALCALCON INChistory →Cash Securities2.94%$6M100.0K
15REGNREGENERON PHARMACEUTICALS INChistory →Cash Securities2.80%$6M20.0K
16EWEDWARDS LIFESCIENCES CORP COM STKhistory →Cash Securities2.77%$5M25.0K
17UNHUNITEDHEALTH GROUP INChistory →Cash Securities2.74%$5M25.0K
18SYKSTRYKER CORP COMhistory →Cash Securities2.73%$5M25.0K
19DGXQUEST DIAGNOSTICS INChistory →Cash Securities2.70%$5M50.0K
20WELLCARE HEALTH PLANS INC COM STKCash Securities2.62%$5M20.0K
21BDXBECTON DICKINSON & CO COM STKhistory →Cash Securities2.55%$5M20.0K
22LABORATORY CORP AMER HLDGS COM STKCash Securities2.54%$5M30.0K
23CELGCELGENE CORP COM STKhistory →Cash Securities2.51%$5M50.0K
24IQVIQVIA HOLDINGS INChistory →Cash Securities2.26%$4M30.0K
25TMOTHERMO FISHER CORPhistory →Cash Securities2.20%$4M15.0K
26MDTMEDTRONIC PLChistory →Cash Securities2.19%$4M40.0K
27INCYINCYTE CORP COM STKhistory →Cash Securities2.06%$4M55.0K
28THCTENET HEALTHCARE CORPhistory →Cash Securities1.95%$4M175.0K
29ZTSZOETIS INChistory →Cash Securities1.89%$4M30.0K
30ELVANTHEM INC COM STKhistory →Cash Securities1.82%$4M15.0K
31AZNNASTRAZENECA PLC ADRhistory →Cash Securities1.80%$4M80.0K
32ISRGINTUITIVE SURGICAL INChistory →Cash Securities1.67%$3M6.1K
33HRCHILL ROM HOLDINGS INChistory →Cash Securities1.59%$3M30.0K
34CICIGNA CORPORATION COM STKhistory →Cash Securities1.53%$3M20.0K
35BMRNBIOMARIN PHARMACEUTICAL INC COM STKhistory →Cash Securities1.53%$3M45.0K
36CNCCENTENE CORP DEL COM STKCash Securities0.87%$2M40.0K
37SEATTLE GENETICS INC COM STKCash Securities0.86%$2M20.0K
38BLUEPRINT MEDICINES CORP CAMB COM STKCash Securities0.74%$1M20.0K
39ACADACADIA PHARMCash Securities0.73%$1M40.0K
40SAGE THERAPEUTICS INC CAMBRID COM STKCash Securities0.71%$1M10.0K
41TDOCTELADOC HEALTH INCCash Securities0.65%$1M19.1K
42SRPTSAREPTA THERAPUTICS INCCash Securities0.57%$1M15.0K
43AAGILENT TECHNOLOGIES INC COM STKCash Securities0.39%$766,00010.0K
44CHRSCOHERUS BIOSCIENCES INCCash Securities0.31%$618,00030.5K
45CHRSCOHERUS BIOSCIENCES INC REDWO COM STKCash Securities0.15%$300,00014.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.